Desmopressin Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 21 USDMF, 15 CEP/COS, 3 JDMF, 4 EU WC, 9 KDMF, 28 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

231 FDF Dossiers, 53 FDA Orange Book, 134 Europe, 10 Canada, 12 Australia, 7 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;NASAL - 0.01%, SPRAY, METERED;NASAL - 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.004MG/ML, TABLET;ORAL - 0.1MG, TABLET;ORAL - 0.2MG, SPRAY, METERED;NASAL - 0.00083MG/SPRAY, SPRAY, METERED;NASAL - 0.00166MG/SPRAY, SPRAY, METERED;NASAL - 0.15MG/SPRAY, SPRAY, METERED;NASAL - 0.01MG/SPRAY, TABLET;SUBLINGUAL - 0.0277MG, TABLET;SUBLINGUAL - 0.0553MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 1 DKSH, 4 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 2 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 18 Kerry, 10 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 7 Roquette, 5 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 4 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 26 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 14 Co-Processed Excipients, 14 Granulation, 13 Lubricants & Glidants, 10 Parenteral, 9 Controlled & Modified Release, 9 Thickeners and Stabilizers, 7 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 4 Surfactant & Foaming Agents, 4 Coating Systems & Additives, 4 Taste Masking, 4 Topical, 3 Film Formers & Plasticizers, 2 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 123 Finished Drug Prices

MARKET PLACE

8 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

15 US Patents, 18 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 17922 / DOSAGE - SPRAY, METERED;NASAL - 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
desmopressin acetate(UNII: XB13HYU18U) (desmopressin - UNII:ENR1LLB0FP)	desmopressin	0.1mg in 1

Inactive Ingredients

Ingredient Name	Amring Pharmaceuticals, Inc.	Ferring Pharmaceuticals Inc.	sanofi-aventis U.S. LLC
BENZALKONIUM CHLORIDE(F5UM2KM3W7)
chlorobutanol(HM4YQM8WRC)
citric acid monohydrate(2968PHW8QP)
Hydrochloric acid(QTT17582CB)
SODIUM CHLORIDE(451W47IQ8X)
sodium phosphate, dibasic, dihydrate(94255I6E2T)

Drug Product Composition: Desmopressin Acetate